|
|
||||||||
and VCAM-1 and Is Rapidly Down-Regulated by a Mechanism Involving T Cells and Expression of Fas1 ,2


*
Laboratory of Experimental Immunology, Division of Basic Sciences, and
Science Applications International Corp. Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702;
Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD 20892; and
§
Department of Oncology, Hoffmann-La Roche, Inc., Nutley, NJ 07110
NK cells have been shown to be important antitumor or antiviral
effector cells in the liver. In the present study we have examined the
factors that regulate the initial recruitment and subsequent fate of
hepatic NK and T cells in mice treated with IL-12 or IL-2. Daily
administration of IL-12 caused a rapid initial increase in NK cells
followed by a subsequent decrease that coincided with an accumulation
of T cells. The recruitment of hepatic NK cells by IL-12, but not the
subsequent T cell infiltrate, was abrogated in IFN-
-/-
mice. In contrast, daily administration of IL-2 caused a sustained
increase in liver-associated NK cells that was not diminished in
IFN-
-/- mice. The IL-12-induced recruitment in both
hepatic NK and T cells was abrogated by in vivo treatment with
anti-VCAM-1 mAbs, while treatment with anti-ICAM-1 Abs
decreased only the recruitment of T cells in the IL-12-treated mice.
The rapid loss of newly recruited hepatic NK cells in IL-12-treated
mice did not occur in SCID mice or in
B.MRL-Faslpr
(Fas-) and
B6Smn.C3H-Faslgld
(FasL-) mutant mice, suggesting that T cells can actively
eliminate hepatic NK cells through a Fas-dependent mechanism. These
findings also imply that during the endogenous innate immune response
to infectious agents or tumors or in the host response induced by
cytokine therapies, the biologic effects of NK cells may be limited by
T cell-mediated effects.
This article has been cited by other articles:
![]() |
B. Gao, S. Radaeva, and O. Park Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases J. Leukoc. Biol., September 1, 2009; 86(3): 513 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Collazo, A. I. Meierovics, R. De Pascalis, T. H. Wu, C. R. Lyons, and K. L. Elkins T Cells from Lungs and Livers of Francisella tularensis-Immune Mice Control the Growth of Intracellular Bacteria Infect. Immun., May 1, 2009; 77(5): 2010 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Hussain, P. He, J. Subleski, L. J. Hofseth, G. E. Trivers, L. Mechanic, A. B. Hofseth, M. Bernard, J. Schwank, G. Nguyen, et al. Nitric Oxide Is a Key Component in Inflammation-Accelerated Tumorigenesis Cancer Res., September 1, 2008; 68(17): 7130 - 7136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Subleski, V. L. Hall, T. C. Back, J. R. Ortaldo, and R. H. Wiltrout Enhanced Antitumor Response by Divergent Modulation of Natural Killer and Natural Killer T Cells in the Liver. Cancer Res., November 15, 2006; 66(22): 11005 - 11012. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Abdool, E. Cretney, A. D. Brooks, J. M. Kelly, J. Swann, A. Shanker, E. W. Bere Jr., W. M. Yokoyama, J. R. Ortaldo, M. J. Smyth, et al. NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function J. Immunol., August 15, 2006; 177(4): 2575 - 2583. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ortaldo, R. T. Winkler-Pickett, E. W. Bere Jr, M. Watanabe, W. J. Murphy, and R. H. Wiltrout In Vivo Hydrodynamic Delivery of cDNA Encoding IL-2: Rapid, Sustained Redistribution, Activation of Mouse NK Cells, and Therapeutic Potential in the Absence of NKT Cells J. Immunol., July 15, 2005; 175(2): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Engwerda, M. Ato, S. Stager, C. E. Alexander, A. C. Stanley, and P. M. Kaye Distinct Roles for Lymphotoxin-{alpha} and Tumor Necrosis Factor in the Control of Leishmania donovani Infection Am. J. Pathol., December 1, 2004; 165(6): 2123 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. A. Portielje, C. H. J. Lamers, W. H. J. Kruit, A. Sparreboom, R. L. H. Bolhuis, G. Stoter, C. Huber, and J. W. Gratama Repeated Administrations of Interleukin (IL)-12 Are Associated with Persistently Elevated Plasma Levels of IL-10 and Declining IFN-{gamma}, Tumor Necrosis Factor-{alpha}, IL-6, and IL-8 Responses Clin. Cancer Res., January 1, 2003; 9(1): 76 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Dokun, D. T. Chu, L. Yang, A. S. Bendelac, and W. M. Yokoyama Analysis of In Situ NK Cell Responses During Viral Infection J. Immunol., November 1, 2001; 167(9): 5286 - 5293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Park, M. E. Gruys, K. McCormick, J.-K. Lee, J. Subleski, J. M. Wigginton, R. G. Fenton, J.-M. Wang, and R. H. Wiltrout Primary Hepatocytes from Mice Treated with IL-2/IL-12 Produce T Cell Chemoattractant Activity that Is Dependent on Monokine Induced by IFN-{{gamma}} (Mig) and Chemokine Responsive to {{gamma}}-2 (Crg-2) J. Immunol., March 15, 2001; 166(6): 3763 - 3770. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wolf, R. Hallmann, G. Sass, M. Sixt, S. Kusters, B. Fregien, C. Trautwein, and G. Tiegs TNF-{{alpha}}-Induced Expression of Adhesion Molecules in the Liver Is Under the Control of TNFR1--Relevance for Concanavalin A-Induced Hepatitis J. Immunol., January 15, 2001; 166(2): 1300 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mortarini, A. Borri, G. Tragni, I. Bersani, C. Vegetti, E. Bajetta, S. Pilotti, V. Cerundolo, and A. Anichini Peripheral Burst of Tumor-specific Cytotoxic T Lymphocytes and Infiltration of Metastatic Lesions by Memory CD8+ T Cells in Melanoma Patients Receiving Interleukin 12 Cancer Res., July 1, 2000; 60(13): 3559 - 3568. [Abstract] [Full Text] |
||||
![]() |
M. Watanabe, R. G. Fenton, J. M. Wigginton, K. L. McCormick, K. M. Volker, W. E. Fogler, P. G. Roessler, and R. H. Wiltrout Intradermal Delivery of IL-12 Naked DNA Induces Systemic NK Cell Activation and Th1 Response In Vivo That Is Independent of Endogenous IL-12 Production J. Immunol., August 15, 1999; 163(4): 1943 - 1950. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |